Illumina

PR Manager (Hybrid/Remote)

California Twp, Michigan, United States

Apply now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in Public Relations, Communications, Journalism, or a related field, and have at least 7 years of experience in public relations, with a focus on corporate communications, preferably within the life sciences or technology industries. Strong experience in media relations, strategic communications planning, and crisis communications is essential. Demonstrated ability to build and maintain relationships with journalists and influencers is required, as is proficiency in developing and executing public relations campaigns.

Responsibilities

The PR Manager will execute strategic public relations plans to support company news and milestones, measure and report results, engage with the media to secure coverage, collaborate with internal teams to develop aligned messaging, engage with stakeholders to identify newsworthy stories, serve as the operations coordinator for the PR function, including project tracking and media list management, and recommend process improvements. The role involves developing work plans, determining resources, and working on complex assignments requiring conceptual thinking and professional judgment.

Skills

Media Relations

Public Relations Strategy

Content Development

Media List Management

Stakeholder Engagement

Project Coordination

Copy Editing

Research and Reporting

Relationship Building

Strategic Planning

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free